^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    GoPath Lab

    i
    Other names: GoPath | GOPATH | GoPath® Diagnostics | GoPath Laboratories | GoPath Lab | GoPath Laboratories LLC | GoPath Global, Inc. | GoPath Global, Inc | GoPath Global Inc. | GoPath Global Inc
    Related tests:
    Evidence

    News

    1m
    OncoAssure and GoPath Diagnostics Announce Agreement for Provision of Next-Generation Prostate Cancer Prognostic Test in US Market (University College Dublin)
    "OncoAssure Ltd...is proud to announce an exclusive partnership with Illinois-based GoPath Diagnostics. Under this agreement, GoPath, a leading full-service CAP-accredited and CLIA-certified anatomic, molecular, and digital pathology company, will hold the exclusive rights to provide the OncoAssure™ Prostate test throughout the United States."
    Licensing / partnership
    |
    OncoAssure Prostate Cancer Test
    3years
    GoPath obtains NY State License for its ProstateNow™ Genetic Test (PRWeb)
    "GoPath Diagnostics...is proud to announce that they have recently earned a clinical laboratory license that grants authorization from the New York State Department of Health to perform its ProstateNow™ test, in addition to already approved, Histopathology and Oncology – Molecular and Cellular Tumor Markers testing. ProstateNow™ is a cutting-edge genetic test that helps individuals determine their risk of developing prostate cancer."
    Regulatory
    |
    PROSTATENOW™
    4years
    GoPath® Diagnostics launches FDA-Cleared CGP Test under OncoTarget® 500 (PRWeb)
    "OncoTarget® 500 assesses cancer pathology by analyzing over 500 genes to detect genetic alterations associated with cancer growth. With OncoTarget® 500, oncologists and researchers may effectively determine the unique genomic profile of individual tumors to determine the most suitable therapies for optimal medical outcomes in a timely manner."
    Launch
    |
    OncoTarget® 500